The Incredible Growth of Medical Grade Chitosan Industry
The Incredible Growth of Medical Grade Chitosan Industry
Chitosan is a linear polysaccharide consisting of randomly distributed β- (1 → 4) -linked D-glucosamine (deacetylated unit) and N-acetyl-D-glucosamine (acetylated unit). It is made by treating the chitin shells of shrimp and other crustaceans with an alkaline substance like sodium hydroxide.Get Sample PDF
Some of the key players of Medical Grade Chitosan Industry:
Primex, KitoZyme, BIO21, YSK, Vietnam Food, NovaMatrix, KIMICA, Ningbo Zhenhai Haixin Biological, Golden-Shell Pharmaceutical, Zhejiang Fengrun Biotech, Jiangsu Shuanglin, Jiangsu Aoxin Biotechnology, Qingdao Yunzhou BiochemistryChitosan has a number of commercial and potential biomedical uses. It can be used in agriculture as a seed treatment and biopesticide, and it helps plants fight off fungal infections. In winemaking, it can be used as a fining agent to prevent spoilage as well. In industry, it can be used in a self-healing polyurethane paint coating. In medicine, it is useful in bandages to reduce bleeding and as an antibacterial agent; It can also be used to deliver medication through the skin.
Chitosan is produced commercially by the deacetylation of chitin, which is the structural element in the exoskeleton of crustaceans (such as crabs and shrimp) and cell walls of fungi. The degree of deacetylation (% DD) can be determined by NMR spectroscopy, and the% DD in commercial chitosans ranges from 60 to 100%. On average, the molecular weight of commercially produced chitosan is 3800-20,000 Daltons.
Comments
Post a Comment